BR100 Increased By (0.27%)
BR30 Increased By (0.15%)
KSE100 Increased By (0.15%)
KSE30 Increased By (0.01%)
BECO 5.92 Decreased By ▼ -0.11 (-1.82%)
BML 57.31 Increased By ▲ 4.56 (8.64%)
BOP 34.09 Decreased By ▼ -0.16 (-0.47%)
CNERGY 8.20 Increased By ▲ 0.04 (0.49%)
DCL 12.15 Decreased By ▼ -0.19 (-1.54%)
FCCL 53.88 Decreased By ▼ -0.01 (-0.02%)
FCSC 5.25 Increased By ▲ 0.03 (0.57%)
FFL 18.01 Decreased By ▼ -0.02 (-0.11%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.23 Increased By ▲ 0.23 (2.09%)
KEL 8.17 Increased By ▲ 0.06 (0.74%)
KOSM 5.47 Increased By ▲ 0.09 (1.67%)
MLCF 88.79 Increased By ▲ 0.74 (0.84%)
NBP 186.50 Increased By ▲ 0.02 (0.01%)
PACE 10.96 Increased By ▲ 0.24 (2.24%)
PAEL 40.42 Increased By ▲ 0.48 (1.2%)
PIAHCLA 26.26 Increased By ▲ 0.09 (0.34%)
PIBTL 17.33 Increased By ▲ 0.01 (0.06%)
PPL 232.00 Decreased By ▼ -0.78 (-0.34%)
PRL 34.70 Decreased By ▼ -0.25 (-0.72%)
PTC 66.80 Decreased By ▼ -0.76 (-1.12%)
SEARL 91.45 Increased By ▲ 0.52 (0.57%)
SSGC 27.15 Decreased By ▼ -0.02 (-0.07%)
TELE 8.70 Increased By ▲ 0.13 (1.52%)
THCCL 65.35 Increased By ▲ 5.22 (8.68%)
TPLP 9.20 Increased By ▲ 0.44 (5.02%)
TREET 24.55 Increased By ▲ 0.01 (0.04%)
TRG 72.63 Increased By ▲ 0.88 (1.23%)
WAVES 10.70 Increased By ▲ 0.72 (7.21%)
WTL 1.26 No Change ▼ 0.00 (0%)
World

Mexico president will get AstraZeneca COVID-19 shot, says risks minimal

  • Lopez Obrador, 67, said the benefits outweighed the risks of the low-cost shot, which is a core pillar of Mexico's vaccination strategy. Several countries have drawn attention to possible links between the vaccine and very rare cases of blood clots.
  • Mexico's health regulator said it was investigating the information, but had no current plans to limit the shot to any age group.
Published April 8, 2021 Updated April 8, 2021 08:18pm
By

MEXICO CITY: Mexico President Andres Manuel Lopez Obrador said on Thursday that he will be vaccinated with the Oxford/AstraZeneca COVID-19 vaccine, a day after Italy and the United Kingdom recommended its use be restricted to some adults.

Lopez Obrador, 67, said the benefits outweighed the risks of the low-cost shot, which is a core pillar of Mexico's vaccination strategy. Several countries have drawn attention to possible links between the vaccine and very rare cases of blood clots.

"(The risks) are minimal for the benefit it causes," Lopez Obrador said at a regular new conference, echoing advice from Britain on Wednesday, which said the shot was safe for the vast majority of people, while recommending it not be used on adults under 30 years old.

Mexico's health regulator said it was investigating the information, but had no current plans to limit the shot to any age group.

Lopez Obrador said earlier this week he planned to get vaccinated within two to three weeks.

Comments

Comments are closed for this article.